Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02269709 · ClinicalTrials.gov registry record · NA

Stage 3 Fontan Operation Liver Ultrasound Study

A NA study of Fontan Operation, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT02269709 is a NA study of Fontan Operation that has completed, run by University of Michigan. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02269709, a NA study of Fontan Operation, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the liver stiffness, which can be caused by congestion and fibrosis in pediatric patients before and after a Fontan heart operation. A new form of ultrasound elastography (Acoustic Radiation Force Impulse, or ARFI) will measure liver stiffness.

Conditions Studied

Interventions

  • DEVICE ARFI Ultrasound

Study Locations (1)

Michigan

  • University of Michigan Hospital - Ann Arbor

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2014-11
Est. Completion 2016-07
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02269709

The ClinicalTrials.gov registry entry for NCT02269709 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fontan Operation appearing as the primary indexed condition, and to 1 intervention - of which ARFI Ultrasound is the first listed.

NCT02269709 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02269709 about?

NCT02269709 is a clinical study titled "Stage 3 Fontan Operation Liver Ultrasound Study". The purpose of this study is to compare the liver stiffness, which can be caused by congestion and fibrosis in pediatric patients before and after a Fontan heart operation. A new form of ultrasound elastography (Acoustic Radiation Force Impulse, or ARFI) will measure liver stiffness.

What is the current status of trial NCT02269709?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2014-11. Estimated completion is 2016-07.

What conditions does trial NCT02269709 study?

This clinical trial studies the following conditions: Fontan Operation.

What interventions are being tested in trial NCT02269709?

The interventions under investigation include: ARFI Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT02269709?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02269709 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.